Healthcare, Regulatory and Reimbursement Landscape - Mexico

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico,  The healthcare market of Mexico has significant potential for growth. The increasing elderly population, prevalence of non-communicable diseases, improvements in regulatory guidelines, government support for the healthcare sector, and the North American Free Trade Agreement, which assures its members protection of intellectual property rights, provide the impetus for the growth of the Mexican pharmaceutical market.

The pharmaceutical market was valued at approximately $10 billion in 2008 and is projected to reach approximately $22.5 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 7%.